Modular Pelvic Exenteration for Advanced Rectal Cancer in Frozen Pelvis.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
16 Nov 2023
Historique:
medline: 17 11 2023
pubmed: 16 11 2023
entrez: 16 11 2023
Statut: epublish

Résumé

BACKGROUND Surgery for locally advanced rectal cancer with frozen pelvis is challenging. Therefore, we designed the "modular pelvic exenteration" surgical strategy to achieve better radical resection. CASE REPORT A 51-year-old man with rectal cancer refused surgery and received chemotherapy and radiotherapy. He was intolerant to chemotherapy and did not respond well to radiotherapy. With cancer progression, he presented at our hospital with emaciation, fatigue, dysuria, bloody urine, bloody stool, and anal pain. Computed tomography and magnetic resonance imaging revealed the rectal tumor involved multiple adjacent organs and caused rectovesical fistula, bilateral hydronephrosis, hydroureterosis, and local pelvic infection. The rectal tumor was fixed in the pelvic cavity, presenting a frozen pelvis pattern. There was no distant metastasis. As the patient could not tolerate chemotherapy, was unsuitable for immune-check point inhibitor because the tumor had microsatellite stability, and did not respond well to radiotherapy, surgical resection seemed the most suitable treatment option. After the patient's anemia and malnutrition improved, our designed modular pelvic exenteration surgery was performed. In this strategy, we divided pelvic organs and tissues into 4 independent modules. After combining the modules planned to be resected, we delineated the pre-resection margin. By this strategy, the tumor was removed en bloc, with a clear resection margin. The patient was discharged 13 days after the operation, without complications. Follow-up for 24 months revealed no signs of tumor recurrence. CONCLUSIONS For locally advanced rectal cancer with frozen pelvis, the modular pelvic exenteration strategy may help to achieve satisfactory surgical effects in selected patients.

Identifiants

pubmed: 37968899
pii: 941684
doi: 10.12659/AJCR.941684
pmc: PMC10660309
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e941684

Références

Eur J Surg Oncol. 2022 Nov;48(11):2284-2291
pubmed: 35031157
Dis Colon Rectum. 2009 Jul;52(7):1223-33
pubmed: 19571697
JNMA J Nepal Med Assoc. 2020 Oct 15;58(230):826-830
pubmed: 34504379
Clin Radiol. 1967 Oct;18(4):403-11
pubmed: 6073910
Indian J Surg Oncol. 2022 Sep;13(3):559-563
pubmed: 35280239
World J Surg Oncol. 2023 Aug 5;21(1):240
pubmed: 37542288
Dis Colon Rectum. 2004 Oct;47(10):1599-606
pubmed: 15540287
Br J Surg. 2001 Jul;88(7):988-93
pubmed: 11442533
Colorectal Dis. 2017 May;19(5):430-436
pubmed: 28267255
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 May 25;23(5):472-479
pubmed: 32842427
J Egypt Natl Canc Inst. 2014 Sep;26(3):167-73
pubmed: 25150132
Dis Colon Rectum. 2022 Dec 1;65(12):1475-1482
pubmed: 35913831
Khirurgiia (Mosk). 2022;(7):45-57
pubmed: 35775844
Colorectal Dis. 2022 Jan;24(1):16-26
pubmed: 34653292
Case Rep Womens Health. 2019 Jun 27;23:e00131
pubmed: 31360641
Updates Surg. 2017 Sep;69(3):403-410
pubmed: 28791628
Eur J Surg Oncol. 2016 Jun;42(6):823-8
pubmed: 26947962
Tumori. 2006 Sep-Oct;92(5):402-6
pubmed: 17168432
Dis Colon Rectum. 2008 Mar;51(3):284-91
pubmed: 18204879
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Tech Coloproctol. 2018 Nov;22(11):835-845
pubmed: 30506497
Int J Colorectal Dis. 2019 Jun;34(6):983-991
pubmed: 31056732
Oncotarget. 2019 Jun 11;10(39):1-13
pubmed: 31231460
Ann Surg. 2019 Feb;269(2):315-321
pubmed: 28938268
Arch Surg. 2001 Jan;136(1):105-12
pubmed: 11146790
World J Surg. 2009 Jul;33(7):1502-8
pubmed: 19421811
Am J Kidney Dis. 2021 Aug;78(2):293-304
pubmed: 33972146
Colorectal Dis. 2023 Apr;25(4):616-623
pubmed: 36408669
Radiographics. 2004 Jan-Feb;24(1):193-208
pubmed: 14730046

Auteurs

Rui Wang (R)

Department of Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China (mainland).

Zhaopeng Yan (Z)

Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China (mainland).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH